Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study

被引：0

作者：

Dickinson, Michael ^{[1
,2
]}

Carlo-Stella, Carmelo ^{[3
,4
]}

Morschhauser, Franck ^{[5
,6
]}

Bachy, Emmanuel ^{[7
]}

Corradini, Paolo ^{[8
,9
]}

Iacoboni, Gloria ^{[10
]}

Khan, Cyrus ^{[11
]}

Wrobel, Thomasz ^{[12
]}

Offner, Fritz ^{[13
]}

Trneny, Marek ^{[14
]}

Wu, Shang-Ju ^{[15
]}

Cartron, Guillaume ^{[16
]}

Hertzberg, Mark ^{[17
,18
]}

Sureda, Anna ^{[19
]}

Perez-Callejo, David ^{[20
]}

Lundberg, Linda ^{[20
]}

Relf, James ^{[21
]}

Clark, Emma ^{[21
]}

Humphrey, Kathryn ^{[21
]}

Hutchings, Martin ^{[22
]}

机构：

[1] Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[2] Univ Melbourne, Melbourne, Vic, Australia

[3] Humanitas Univ, Milan, Italy

[4] IRCCS Humanitas Res Hosp, Milan, Italy

[5] Hop Claude Huriez, Lille, France

[6] CHU Lille, Lille, France

[7] Ctr Hosp Lyon Sud, Lyon, France

[8] Univ Milan, Milan, Italy

[9] IRCSS Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci, Milan, Italy

[10] Vall dHebron Univ Hosp, Barcelona, Spain

[11] Allegheny Hlth Network, Pittsburgh, PA USA

[12] Uniwersytet Med Wroclawiu, Wroclaw, Poland

[13] Univ Ziekenhuis Gent, Ghent, Belgium

[14] Charles Univ Hosp, Prague, Czech Republic

[15] Natl Taiwan Univ Hosp, Taipei, Taiwan

[16] CHU Montpellier, Montpellier, France

[17] Prince Wales Hosp, Sydney, NSW, Australia

[18] Univ New South Wales, Sydney, NSW, Australia

[19] Inst Catala Oncol Hosp, Barcelona, Spain

[20] F Hoffmann La Roche Ltd, Basel, Switzerland

[21] Roche Prod Ltd, Welwyn Garden City, Herts, England

[22] Rigshosp, Copenhagen, Denmark

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

ABCL; glofitamab; diffuse large B-cell lymphoma; bispecific antibody; relapsed/refractory; phase II;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ABCL-478

引用

页码：S435 / S435

页数：1

共 50 条

[31] Five-Year Subgroup Analysis of Tafasitamab plus Lenalidomide From the Phase II L-MIND Study in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Duell, Johannes
Abrisqueta, Pau
Dreyling, Martin
Gaidano, Gianluca
Gonzalez Barca, Eva
Jurczak, Wojciech
Maddocks, Kami J.
Menne, Tobias
Nagy, Zsolt
Tournilhac, Olivier
Bakuli, Abhishek
Amin, Aasim
Gurbanov, Konstantin
Salles, Gilles
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S436 - S437
[32] Treatments for Relapsed-Refractory Diffuse Large B-cell Lymphoma: A Preliminary Evaluation of the Place in Therapy of Glofitamab, a Bispecific Monoclonal Antibody
Messori, Andrea
Rivano, Melania
Mengato, Daniele
Chiumente, Marco
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
[33] Glofitamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma: Extended Follow-Up from a Pivotal Phase 2 Study and Subgroup Analyses in Patients with Prior Chimeric Antigen Receptor T-Cell Therapy and by Baseline Total Metabolic Tumor Volume
Hutchings, Martin
Carlo-Stella, Carmelo
Morschhauser, Franck
Falchi, Lorenzo
Bachy, Emmanuel
Cartron, Guillaume
Khan, Cyrus
Tani, Monica
Martinez-Lopez, Joaquin
Bartlett, Nancy L.
Salar, Antonio
Brody, Joshua
Leppa, Sirpa
Baumlin, Pauline
Mulvihill, Estefania
Relf, James
Xie, Yuying
Kaufman, Derrick
Lundberg, Linda
Dickinson, Michael
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S473 - S473
[34] Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma
Miller, Sally D.
Lozano-Ortega, Greta
Mutebi, Alex
Briggs, Owanate
Sail, Kavita
Elliott, Brian
Kalsekar, Anupama
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (01)
[35] Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphoma
Izutsu, Koji
Kumode, Takahiro
Yuda, Junichiro
Nagai, Hirokazu
Mishima, Yuko
Suehiro, Youko
Yamamoto, Kazuhito
Fujisaki, Tomoaki
Ishitsuka, Kenji
Ishizawa, Kenichi
Ikezoe, Takayuki
Nishikori, Momoko
Akahane, Daigo
Fujita, Jiro
Dinh, Minh
Soong, David
Noguchi, Hidehisa
Buchbjerg, Jeppe Klint
Favaro, Elena
Fukuhara, Noriko
CANCER SCIENCE, 2023, 114 (12) : 4643 - 4653
[36] Prolonged Cytopenias in Autologous Stem Cell Transplantation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Santapuram, Pranav
Rupji, Manali
Graiser, Michael
Waller, Edmund
Blum, Kristie
Allen, Pamela
Koff, Jean
Heffner, Leonard
Lechowicz, Mary
Lonial, Sagar
Kaufman, Jonathan
Dhopadkar, Madhav
Nooka, Ajay
Blum, William
Klisovic, Rebecca
Joseph, Nisha
Gupta, Vikas
Langston, Amelia
Cohen, Jonathan
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S396 - S397
[37] Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma
Vacirca, Jeffrey L.
Acs, Peter I.
Tabbara, Imad A.
Rosen, Peter J.
Lee, Peter
Lynam, Eric
ANNALS OF HEMATOLOGY, 2014, 93 (03) : 403 - 409
[38] Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma
Nastoupil, Loretta J.
Kuruvilla, John
Chavez, Julio C.
Bijou, Fontanet
Witzig, Thomas E.
Santoro, Armando
Flinn, Ian W.
Boccomini, Carola
Kenkre, Vaishalee P.
Corradini, Paolo
Isufi, Iris
Andorsky, David J.
Klein, Leonard M.
Greenwald, Daniel R.
Sangha, Randeep
Shen, Frank
Hagner, Patrick
Li, Yan
Dobmeyer, Juergen
Gong, Nian
Uttamsingh, Shailaja
Pourdehnad, Michael
Ribrag, Vincent
EJHAEM, 2022, 3 (02): : 394 - 405
[39] Brentuximab Vedotin (BV) in Combination With Lenalidomide (Len) and Rituximab (R) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Results From the Phase 3 ECHELON-3 Study
Yasenchak, Christopher
Kim, Jeong-A
Hahn, Uwe
Kim, Won-Seog
Fleury, Isabelle
Laribi, Kamel
Bergua Burgues, Juan Miguel
Bouabdallah, Krimo
Forward, Nicholas
Bijou, Fontanet
MacDonald, David
Portell, Craig
Ghesquieres, Herve
Nowakowski, Grzegorz
Rustia, Evelyn
Fanale, Michelle
Jie, Fei
Bartlett, Nancy
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S490 - S491
[40] Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma
Hideki Goto
Shinichi Makita
Koji Kato
Kota Tokushige
Taizo Fujita
Koichi Akashi
Koji Izutsu
Takanori Teshima
International Journal of Clinical Oncology, 2020, 25 : 1736 - 1743

← 1 2 3 4 5 →